GlaxoSmithKline Pharmaceuticals, with its shares currently priced at Rs 3,292.30, remains a key stock to watch, particularly ...

This morning, GlaxoSmithKline announced a $3 billion criminal settlement with the Department of Justice to settle accusations that it didn't tell regulators about safety problems with an infamous ...

The 12-year-old company had been collaborating with British pharmaceutical giant GlaxoSmithKline on an immuno-oncology drug ...

GlaxoSmithKline PLCGSK-0.10%decrease; red down pointing triangle on Monday said it would buy cancer-focused drug company Tesaro Inc. for about $4.16 billion, positioning the health-care giant in a ...

Pharmaceutical giant GlaxoSmithKline will shutter its Clifton oral care manufacturing plant on Thursday, and lay off 165 employees, the London-based firm confirmed today. The plant closure is part ...

Here's how Sir Andrew Witty, who is due to end an eight-year tenure as the chief executive of British drug giant GlaxoSmithKline, would like to be remembered: in his shirtsleeves, in sub-Saharan ...

Dozens of states are suing to block 23andMe's sale of personal genetic data, citing concerns over customer consent and ...

Pharmaceutical giant GlaxoSmithKline is sidestepping its pledge to lower asthma inhaler prices, a key senator charged Wednesday, in the latest effort by Democrats to pressure drug companies on the ...

LONDON—GlaxoSmithKline PLC lowered its earnings outlook on Wednesday, as its second-quarter profit was hit by weak respiratory-drug sales in the U.S., currency moves and a continuing bribery ...

GlaxoSmithKline agreed on Sept. 17 to settle out of the first Zantac trial in California, which began this month in Oakland. GSK won two defense verdicts in Illinois earlier this year but faced ...

GlaxoSmithKline PLC is a pharmaceutical giant that operates on a global scale. The company has already released research and medications that saved millions of lives. Explore the global leaders of ...

April 25 (Reuters) - GlaxoSmithKline (GLAX.NS), opens new tab sued Pfizer (PFE.N), opens new tab and BioNTech (22UAy.DE), opens new tab in Delaware federal court on Thursday, accusing them of ...